Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2013 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BGC PARTNERS INC | 30 | Q4 2022 | 1.9% |
ISHARES TR | 22 | Q2 2023 | 2.8% |
VANECK VECTORS ETF TRUST | 21 | Q3 2022 | 7.0% |
SPDR SP 500 ETF TR | 20 | Q3 2023 | 8.8% |
MAGNACHIP SEMICONDUCTOR CORP | 19 | Q3 2022 | 1.1% |
NXP SEMICONDUCTORS N V | 18 | Q4 2020 | 2.9% |
MICROSOFT CORP | 18 | Q2 2020 | 1.5% |
ISHARES TR | 17 | Q1 2023 | 7.5% |
CYPRESS SEMICONDUCTOR CORP | 17 | Q1 2019 | 2.5% |
AEROJET ROCKETDYNE HLDGS INC | 17 | Q2 2022 | 1.4% |
View K2 PRINCIPAL FUND, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AcuityAds Holdings Inc. | March 16, 2023 | 3,198,531 | 5.6% |
ARS Pharmaceuticals, Inc. | February 13, 2023 | 2,045,348 | 2.2% |
Solid Biosciences Inc. | February 13, 2023 | 284,871 | 1.5% |
TCR2 THERAPEUTICS INC. | February 09, 2023 | 10 | 0.0% |
AVROBIO, Inc. | February 08, 2023 | 10 | 0.0% |
Goldenstone Acquisition Ltd. | February 08, 2023 | 10 | 0.0% |
Relativity Acquisition Corp | February 08, 2023 | 10 | 0.0% |
Sagaliam Acquisition Corp | February 08, 2023 | 10 | 0.0% |
Pasithea Therapeutics Corp. | February 01, 2022 | 1,094,418 | 5.0% |
Ignyte Acquisition Corp. | January 26, 2022 | 259,958 | 3.6% |
View K2 PRINCIPAL FUND, L.P.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G | 2024-02-09 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-15 |
13F-HR | 2023-05-11 |
SC 13G/A | 2023-03-16 |
SC 13G | 2023-03-16 |
View K2 PRINCIPAL FUND, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.